Johnson & Johnson beat analyst expectations in the third quarter but left Wall Street wanting more; BMS dominated the news ...
The Seattle-based nonprofit plans to more than double testing volume for the functional cancer test, called the PARIS Test®, ...
Oversubscribed financing led by Juvia Group, welcomes an expanded syndicate of leading institutional investors, reflecting ...
Today, the Honourable Marjorie Michel, Minister of Health, announced the appointment of Dr. George Mutwiri to the Canadian ...
(NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy ...
Evaluating subcutaneous SKYRIZI against stringent endoscopic outcomes demonstrates its potential to help CD patients achieve ...
Preliminary findings from Part 1 of the Phase 2/3 ANDECAL study highlight a potential therapeutic approach for fibrodysplasia ...
While Alnylam’s recent reduced revenue guidance spooked investors, analysts remain broadly bullish on the biotech’s ...
While industry leaders are unsure whether the U.S. or China will prevail, they are largely united in the belief that Europe ...
Published in Antimicrobial Agents and Chemotherapy, the peer-reviewed study is the first to directly compare AvantGuard’s new ...
Former Genentech Senior Vice President Brings More Than 25 Years of Biopharma Experience to Guide Continued Growth and ...
The first-time CEO says her own sponsors took chances on her—and that industry leaders need to do the same to rebuild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results